Serotonin releasing agent

From Wikipedia, the free encyclopedia
Jump to: navigation, search

A serotonin releasing agent (SRA) is a type of drug which induces the release of serotonin into the neuronal synaptic cleft, with less significant or no efficacy in producing neurotransmitter efflux at other types of monoamine neurons.

List of serotonin releasing agents[edit]

Fenfluramine, the prototypical SSRA, previously used as an anorectic before being withdrawn from the market due to toxicity concerns.
Pharmaceutical Drugs
Research Chemicals

Examples and use[edit]

MDMA, MDEA, MDA, and MBDB, among other relatives (see MDxx), are recreational drugs termed entactogens. They act as releasing agents of not only serotonin, but of dopamine and norepinephrine as well, and also agonize serotonin receptors such as 5-HT2A.

Fenfluramine, chlorphentermine, and aminorex were used as appetite suppressants but they were discontinued due to concerns of cardiac valvulopathy. This side effect has been attributed not only to their action as SRAs but due to potent agonism of the 5-HT2B receptor as well. The designer drugs MDMA and 4-methylaminorex which are also SRAs and 5-HT2B agonists have been reported to cause this effect as well.

Many tryptamines, such as DMT, DET, DPT, DiPT, psilocin, and bufotenin are SRAs as well as non-selective serotonin receptor agonists.[1] These drugs are serotonergic psychedelics, which is a consequence of their ability to activate the 5-HT2A receptor.

αET and αMT, also tryptamines, are serotonin, norepinephrine, and dopamine releasing agents and non-selective serotonin receptor agonists which were formerly used as antidepressants.[1] They have since been discontinued and are now encountered solely as recreational drugs.

Tramadol, in addition to its opioid and norepinephrine reuptake-inhibiting effects, is an SRA and is used as an analgesic. Indeloxazine is an SRA and norepinephrine reuptake inhibitor used as a nootropic and neuroprotective.

See also[edit]

References[edit]

  1. ^ a b Blough BE, Landavazo A, Decker AM, Partilla JS, Baumann MH, Rothman RB (October 2014). "Interaction of psychoactive tryptamines with biogenic amine transporters and serotonin receptor subtypes". Psychopharmacology 231 (21): 4135–44. doi:10.1007/s00213-014-3557-7. PMID 24800892. 

Further reading[edit]